Clinical trials
Recruiting Phase 1 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 14 |
| 2023 | 22 |
| 2024 | 40 |
| 2025 | 32 |
| 2026 | 26 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 152 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 7 |
| Novartis Pharmaceuticals | 5 |
| M.D. Anderson Cancer Center | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| BeOne Medicines | 3 |
| Chongqing Precision Biotech Co., Ltd | 3 |
| Eli Lilly and Company | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Baylor College of Medicine | 2 |
| Baylor Research Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 152 |
| Ovarian Neoplasms | 31 |
| Carcinoma, Non-Small-Cell Lung | 25 |
| Lung Neoplasms | 23 |
| Stomach Neoplasms | 23 |
| Colorectal Neoplasms | 22 |
| Neoplasm Metastasis | 22 |
| Triple Negative Breast Neoplasms | 22 |
| Pancreatic Neoplasms | 19 |
| Prostatic Neoplasms | 18 |
Trials
Showing 1 to 25 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.